If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
708.00    10.00 (1.43%)
Bid:
708.00
Ask:
709.00
Spread: 1.00 (0.141%)
Market Cap: £1.91b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Director/PDMR Shareholding

11 Feb 2016 16:24

RNS Number : 8442O
CMC Markets Plc
11 February 2016
 

11 February 2016

CMC MARKETS PLC ("CMC")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs")

In accordance with the UK Financial Conduct Authority's Disclosure Rules and Transparency Rules ("DTRs"), CMC announces that as of 11 February 2016 the Directors of the Company and Persons Discharging Managerial Responsibilities ("PDMRs") have the following interests in CMC's ordinary shares ("Shares"):

Name of Director/ PDMR/ Connected Person

Number of Shares prior to Admission

Number of Shares sold pursuant to the Offer

Number of Shares immediately followingAdmission[1]

 

Peter Cruddas

249,610,638[2]

69,680,732[3]

179,929,906[4]

 

David Fineberg

21,688

 

0

21,688

Simon Waugh

0

 

0

25,000

Manjit Wolstenholme

0

0

12,500

Malcolm McCaig

0

 

0

12,500

Notes:

(1) Admission occurred on 10 February 2016

(2) Includes an interest in 68,816,298 Shares held by Fiona Cruddas

(3) Includes an interest in 54,041,766 Shares held by Fiona Cruddas

(4) Post-Admission shareholding includes an interest in 14,774,532 Shares held by Fiona Cruddas and a right to re-delivery under a Stock Lending Agreement with Morgan Stanley & Co. International Plc and Goldman Sachs Strategic Investments (U.K.) Limited in respect of 6,797,607 Shares.

 

On 10 February 2016, as disclosed in the Prospectus, Simon Waugh, Manjit Wolstenholme and Malcolm McCaig, Non-Executive Directors of CMC, were issued and allotted ordinary shares in CMC at a price of £2.40 per share.

In addition to the interests set out above, effective as of 10 February 2016, Grant Foley, Chief Financial Officer and Head of Risk of CMC, and David Fineberg, Group Director of Trading of CMC, were granted awards over ordinary shares of CMC under the CMC Management Equity Plan 2015 ("Management Equity Plan"), as follows:

 

PDMR

Value of shares under awards at IPO offer price of £2.40 per share

Grant Foley

£883,560

David Fineberg

£1,249,680

 

· The grant of awards under the Management Equity Plan was for nil consideration.

· The vesting of such awards is not subject to the satisfaction of a performance condition. These awards will vest as to half on each of the first and second anniversary of Admission.

This notification is made pursuant to DTR 3.1.4. CMC was notified of the above transactions on 11 February 2016.

 

Enquiries:

 

Jonathan Bradshaw

Company Secretary

CMC Markets plc

Tel: 020 7170 8200

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUAANRNKAUAAR
Date   Source Headline
25th Feb 20257:00 amRNSDirectorate Change
6th Feb 20253:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
13th Jan 202510:08 amRNSDirector/PDMR Shareholding
6th Jan 20254:24 pmRNSDirector/PDMR Shareholding
6th Dec 202411:49 amRNSDirector/PDMR Shareholding
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.